Trulicity (dulaglutide) is not FDA-approved for weight loss, but it often causes weight loss as a side effect in people taking it for type 2 diabetes. It belongs to the same drug class as Ozempic and Wegovy, the GLP-1 receptor agonists, and works through similar pathways that reduce appetite and slow digestion. Some doctors prescribe it off-label specifically for weight loss, though getting insurance to cover it for that purpose is a different story.
How Trulicity Causes Weight Loss
Trulicity mimics a natural gut hormone called GLP-1 that your body releases after eating. This hormone signals your brain that you’re full and slows the rate at which food leaves your stomach. The result is that you feel satisfied longer after meals, eat less overall, and take in fewer calories without white-knuckling through hunger. It also improves your body’s insulin response, which helps regulate blood sugar and can reduce the cycle of cravings and energy crashes that drives overeating in people with insulin resistance.
These effects aren’t unique to Trulicity. All GLP-1 medications work through this basic mechanism. What differs between them is potency, dosing, and whether the manufacturer pursued FDA approval specifically for obesity. Eli Lilly, which makes Trulicity, chose to market it for diabetes rather than weight management.
How Much Weight People Actually Lose
The clearest data comes from the AWARD-11 clinical trial, which tested Trulicity at three doses in people with type 2 diabetes who were already taking metformin. Over 36 weeks, participants on the standard 1.5 mg dose lost an average of about 3.1 kg (roughly 7 pounds). Those on the higher 3.0 mg dose lost about 4.0 kg (nearly 9 pounds), and the 4.5 mg dose produced an average loss of 4.7 kg (about 10 pounds).
These numbers are modest compared to what’s seen with semaglutide (Wegovy), where clinical trials show average losses of 15% or more of body weight. Trulicity’s weight loss tends to be more in the range of 5 to 10 pounds for most people, though individual results vary widely. Some people lose significantly more, particularly if they combine the medication with dietary changes and exercise. Others see little change on the scale even as their blood sugar improves.
The higher doses (3.0 mg and 4.5 mg) were statistically superior to the 1.5 mg dose for weight loss in the trial, so if weight management is a goal alongside diabetes control, your doctor may consider dose escalation.
Common Side Effects
The same mechanism that suppresses appetite can also cause digestive discomfort, especially in the first few weeks. In clinical trials, up to 21% of people taking Trulicity experienced nausea, about 14% had diarrhea, and roughly 12% dealt with vomiting. These side effects tend to be worst when starting the medication or moving to a higher dose, and they typically ease over time as your body adjusts.
Some of the early weight loss people see on Trulicity is actually driven by these GI side effects rather than the appetite suppression alone. Feeling nauseous naturally leads to eating less. As the nausea fades, the rate of weight loss often slows, though the appetite-reducing effects of the drug continue working in the background. Eating smaller meals, avoiding high-fat foods, and staying hydrated can help manage the digestive symptoms during the adjustment period.
Insurance Rarely Covers It for Weight Loss
This is the practical barrier most people run into. Because Trulicity is FDA-approved only for type 2 diabetes (and cardiovascular risk reduction in certain adults), insurance plans generally won’t cover it when prescribed purely for weight loss. Medicare Part D, for example, will cover Trulicity for diabetes management but specifically excludes coverage for weight loss purposes. Most private insurers follow a similar policy, tying coverage to the drug’s approved indications.
Without insurance, Trulicity can cost several hundred dollars per month. If your primary goal is weight loss and you don’t have type 2 diabetes, medications that are actually approved for obesity, like semaglutide (Wegovy) or tirzepatide (Zepbound), are more likely to be covered by your plan and have stronger clinical evidence for that specific use. If you do have type 2 diabetes and want a medication that addresses both blood sugar and weight, Trulicity is a reasonable option, and insurance is far more likely to approve it.
How Trulicity Compares to Other GLP-1 Medications
Trulicity is a once-weekly injection, which it shares with Ozempic and Wegovy. All three are GLP-1 receptor agonists. The key differences come down to the active ingredient and how aggressively they drive weight loss. Semaglutide (the drug in both Ozempic and Wegovy) produces roughly two to three times more weight loss than dulaglutide at comparable treatment durations. Tirzepatide (Mounjaro/Zepbound) targets two gut hormones instead of one and produces even greater weight loss in trials.
For someone whose primary concern is losing weight, Trulicity is not the strongest option in this drug class. But for someone managing type 2 diabetes who would also benefit from some weight loss, it remains a widely prescribed and effective choice. It has a long track record, and many people tolerate it well after the initial adjustment period. The decision between GLP-1 medications often comes down to what your insurance covers, what side effects you can tolerate, and whether diabetes management or weight loss is the bigger priority.